News & Updates
Filter by Specialty:
Post-treatment HBsAg loss greater with TDF vs entecavir
12 Jun 2023
In patients with chronic hepatitis B (CHB) without cirrhosis, the rates of hepatitis B surface antigen (HBsAg) loss appear to be higher after discontinuation of tenofovir disoproxil fumarate (TDF) than of entecavir, and this is particularly true for patients who have not experienced relapse after treatment discontinuation, according to a study.
Post-treatment HBsAg loss greater with TDF vs entecavir
12 Jun 2023
Flavonoid intake improves survival after CRC diagnosis
11 Jun 2023
Patients who have been diagnosed with colorectal cancer (CRC) may benefit from increased flavonoid intake, which has been shown to reduce CRC-specific mortality in a recent study.
